메뉴 건너뛰기




Volumn 27, Issue 3, 2013, Pages 211-213

Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus

Author keywords

Glycated albumin; Glycemic excursion; HbA1c; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

EID: 84876909036     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.12.001     Document Type: Article
Times cited : (29)

References (15)
  • 1
    • 84859136502 scopus 로고    scopus 로고
    • Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes
    • R. Bouchi, T. Babazono, M. Mugishima, N. Yoshida, I. Nyumura, and K. Toya Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes Journal of Diabetes Investigation 3 2012 148 155
    • (2012) Journal of Diabetes Investigation , vol.3 , pp. 148-155
    • Bouchi, R.1    Babazono, T.2    Mugishima, M.3    Yoshida, N.4    Nyumura, I.5    Toya, K.6
  • 2
    • 0017835519 scopus 로고
    • The glycosylation of hemoglobin: Relevance to diabetes mellitus
    • H.F. Bunn, K.H. Gabbay, and R.M. Gallop The glycosylation of hemoglobin: Relevance to diabetes mellitus Science 200 1978 21 27
    • (1978) Science , vol.200 , pp. 21-27
    • Bunn, H.F.1    Gabbay, K.H.2    Gallop, R.M.3
  • 3
    • 0033592101 scopus 로고    scopus 로고
    • Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
    • The DECODE study group Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria Lancet 354 1999 617 621
    • (1999) Lancet , vol.354 , pp. 617-621
  • 4
    • 84857217561 scopus 로고    scopus 로고
    • International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
    • A. Kashiwagi, M. Kasuga, E. Araki, Y. Oka, T. Hanafusa, and H. Ito International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values J Diab Invest 3 2012 39 40
    • (2012) J Diab Invest , vol.3 , pp. 39-40
    • Kashiwagi, A.1    Kasuga, M.2    Araki, E.3    Oka, Y.4    Hanafusa, T.5    Ito, H.6
  • 5
    • 58849150951 scopus 로고    scopus 로고
    • A1C variability and the risk of microvascular complications in type 1 diabetes: Data from the Diabetes Control and Complications Trial
    • E.S. Kilpatrick, A.S. Rigby, and S.L. Atkin A1C variability and the risk of microvascular complications in type 1 diabetes: Data from the Diabetes Control and Complications Trial Diabetes Care 31 2008 2198 2202
    • (2008) Diabetes Care , vol.31 , pp. 2198-2202
    • Kilpatrick, E.S.1    Rigby, A.S.2    Atkin, S.L.3
  • 7
    • 33745600098 scopus 로고    scopus 로고
    • Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients
    • M. Koga, M. Matsumoto, H. Saito, and S. Kasayama Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients Endocrine Journal 53 2006 387 391
    • (2006) Endocrine Journal , vol.53 , pp. 387-391
    • Koga, M.1    Matsumoto, M.2    Saito, H.3    Kasayama, S.4
  • 8
    • 77957740531 scopus 로고    scopus 로고
    • Clinical impact of glycated albumin as another glycemic control marker
    • M. Koga, and S. Kasayama Clinical impact of glycated albumin as another glycemic control marker Endocrine Journal 57 2010 751 762
    • (2010) Endocrine Journal , vol.57 , pp. 751-762
    • Koga, M.1    Kasayama, S.2
  • 9
    • 0036774115 scopus 로고    scopus 로고
    • An enzymatic method for the measurement of glycated albumin in biological samples
    • T. Kouzuma, T. Usami, M. Yamakoshi, M. Takahashi, and S. Imamura An enzymatic method for the measurement of glycated albumin in biological samples Clinica Chimica Acta 324 2002 61 71
    • (2002) Clinica Chimica Acta , vol.324 , pp. 61-71
    • Kouzuma, T.1    Usami, T.2    Yamakoshi, M.3    Takahashi, M.4    Imamura, S.5
  • 10
    • 84859078100 scopus 로고    scopus 로고
    • Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes
    • Y. Saisho, K. Tanaka, T. Abe, A. Shimada, T. Kawai, and H. Itoh Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes Diabetology International 2 2011 146 153
    • (2011) Diabetology International , vol.2 , pp. 146-153
    • Saisho, Y.1    Tanaka, K.2    Abe, T.3    Shimada, A.4    Kawai, T.5    Itoh, H.6
  • 12
    • 77649199406 scopus 로고    scopus 로고
    • Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM)
    • T. Suwa, A. Ohta, T. Matsui, R. Koganei, H. Kato, and T. Kawata Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM) Endocrine Journal 57 2010 135 140
    • (2010) Endocrine Journal , vol.57 , pp. 135-140
    • Suwa, T.1    Ohta, A.2    Matsui, T.3    Koganei, R.4    Kato, H.5    Kawata, T.6
  • 13
    • 0028988142 scopus 로고
    • Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
    • Y. Tahara, and K. Shima Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level Diabetes Care 18 1995 440 447
    • (1995) Diabetes Care , vol.18 , pp. 440-447
    • Tahara, Y.1    Shima, K.2
  • 14
    • 0033047374 scopus 로고    scopus 로고
    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
    • M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, and A. Sekikawa Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 1999 920 924
    • (1999) Diabetes Care , vol.22 , pp. 920-924
    • Tominaga, M.1    Eguchi, H.2    Manaka, H.3    Igarashi, K.4    Kato, T.5    Sekikawa, A.6
  • 15
    • 70350539523 scopus 로고    scopus 로고
    • A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes
    • J. Wadén, C. Forsblom, L.M. Thorn, D. Gordin, M. Saraheimo, and P.H. Groop A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes Diabetes 58 2009 2649 2655
    • (2009) Diabetes , vol.58 , pp. 2649-2655
    • Wadén, J.1    Forsblom, C.2    Thorn, L.M.3    Gordin, D.4    Saraheimo, M.5    Groop, P.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.